Repeated liver injury can cause scarring that stiffens the liver and gradually reduces its ability to function. Learn about symptoms and treatment for this often-silent liver condition.
Update Date: 19.03.2026
Liver fibrosis is a condition in which the liver is damaged again and again over time, leading to the gradual buildup of scar tissue. This damage is most often caused by conditions such as steatotic liver disease, heavy alcohol use or chronic viral hepatitis. As scar tissue replaces healthy liver tissue, the liver becomes less flexible and its ability to function may begin to decline. Fibrosis develops throughout the whole liver over time rather than forming a lump or growth such as a tumor or cancer.
If the cause of liver injury is not treated or controlled, fibrosis can progress and eventually lead to cirrhosis, a more advanced stage of liver disease in which extensive scarring causes lasting changes to the liver's structure and function. Cirrhosis can result in serious complications, including liver failure and a higher risk of liver cancer.
Hearing the term "liver fibrosis" can cause worry. Although fibrosis reflects liver damage over time, it does not always mean the damage is permanent. Evidence shows that early stages of fibrosis may stabilize or improve when the underlying cause of liver injury is found and treated.
Liver fibrosis itself usually does not cause symptoms, especially in the early stages. Many people with fibrosis feel well and do not know they have liver scarring until it is found during blood tests or imaging done for another reason.
When symptoms are present, they are often related to the condition causing liver injury, such as steatotic liver disease, alcohol-related liver disease or chronic viral hepatitis, rather than the scarring itself.
Symptoms that reflect worsening liver function or complications of advanced liver disease may include:
The presence of these symptoms may indicate a lot of liver damage and should be checked by a healthcare professional right away.
Make an appointment with a healthcare professional if you have any of the symptoms of liver fibrosis.
Liver fibrosis happens as a result of ongoing inflammation and injury in the liver. This damage activates the body's wound-healing response. When liver injury continues over time, scar tissue forms and slowly replaces healthy liver tissue. This process is driven by chronic liver disease rather than a single episode of liver damage.
In developed countries, the most common causes of liver fibrosis are conditions related to metabolic health, including metabolic dysfunction-associated steatotic liver disease linked to obesity, type 2 diabetes and insulin resistance. Heavy or long-term alcohol use is another leading cause of ongoing liver injury and fibrosis.
Chronic viral hepatitis also can lead to liver fibrosis. Hepatitis B remains a common cause of fibrosis worldwide, particularly in regions where the condition happens early in life. Hepatitis C, once a major cause of liver fibrosis, is now almost universally curable with antiviral treatment when found and treated early.
Other, less common causes of liver fibrosis include autoimmune liver diseases, inherited liver conditions, and diseases that damage or block the bile ducts. If the cause of liver injury is not treated or controlled, scar tissue can continue to build up and fibrosis may worsen over time.
Risk factors are conditions or behaviors that increase the chance of developing liver fibrosis or make liver damage more likely to get worse.
Factors associated with a higher risk of liver fibrosis include:
Having more than one risk factor can increase the likelihood that liver fibrosis will happen or get worse.
Liver fibrosis increases the risk of long-term liver issues if scarring continues to worsen over time. Complications are not common in early fibrosis and are more likely to occur when fibrosis becomes advanced or changes to cirrhosis.
As healthy liver tissue is slowly replaced by scar tissue, the liver may become less able to carry out its regular functions. In the earlier stages, this decline in function may be hard to notice and is often found with blood tests rather than through symptoms. Over time, impaired liver function can affect how the body processes medicines, regulates blood components and clears toxins from the bloodstream.
When fibrosis changes to cirrhosis, more-serious complications can occur, including:
Finding conditions that cause liver injury early and treating them can help reduce the risk of worse complications.
Liver fibrosis may be prevented or slowed by reducing ongoing liver damage and treating liver disease early. Addressing risk factors before a lot of scarring develops can help protect liver health and reduce the likelihood of advanced liver disease.
These steps may help prevent liver fibrosis:
Healthcare professionals diagnose liver fibrosis by reviewing medical history, doing a physical exam and using tests to look for signs of liver damage and scarring. Because early fibrosis often causes no symptoms, testing is usually done based on risk factors or test results outside of the standard range rather than symptoms alone.
Tests used to diagnose or evaluate liver fibrosis may include:
Liver fibrosis does not have a single treatment. Instead, care focuses on treating the cause of liver injury and reducing factors that continue to damage the liver.
Management focuses on improving metabolic health in people with metabolic-associated steatotic liver disease (MASLD). This condition is commonly linked to excess body weight, insulin resistance and type 2 diabetes. A more severe form, metabolic-associated steatohepatitis (MASH), involves liver inflammation and can lead to fibrosis.
Weight loss, improved nutrition and regular physical activity can reduce liver inflammation and may slow or improve fibrosis. Depending on your situation, treating related conditions such as high cholesterol and high blood pressure also may be part of care. For some people, weight-loss medicines or weight-loss surgery may be part of a comprehensive weight management approach.
Stopping alcohol use is the most important step in preventing further liver damage. Support programs, counseling and medical treatment may help people reduce or stop drinking. Continued alcohol use increases the risk that fibrosis will worsen and change to cirrhosis.
Antiviral medicines are used to treat hepatitis B and hepatitis C. Effective treatment can lessen ongoing liver inflammation and lower the risk that fibrosis will worsen. Hepatitis C is often curable with modern antiviral therapy when diagnosed and treated early.
Medicines that affect immune system activity may be used to control inflammation in conditions such as autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. Treatment plans are individualized and typically guided by specialists.
Researchers are studying new ways to slow, stop or possibly reverse liver scarring by targeting the processes that cause fibrosis. These approaches include medicines and cell-based therapies designed to reduce inflammation, limit scar tissue formation or support liver repair.
Other research is exploring how interactions among liver cells, the immune system and gut bacteria may affect whether fibrosis worsens. These treatments are still being studied and are not part of standard care.
The outlook for liver fibrosis varies widely and depends on the cause of liver disease, the amount of scarring present and how early treatment begins.
In many people, liver fibrosis worsens slowly and may remain stable for years. When the cause of liver injury is found and treated early, fibrosis may stop worsening and, in some people, partially improve. This is especially true when risk factors such as excess body weight, type 2 diabetes or alcohol use are effectively managed.
Advanced fibrosis carries a higher risk of worsening to cirrhosis and related complications. Once cirrhosis develops, lasting changes can occur to the liver's structure and function, increasing the risk of liver failure and liver cancer.
Because liver fibrosis often causes few or no symptoms, ongoing monitoring is important, even when you feel well. Healthcare professionals may use blood tests and imaging over time to assess liver health and guide care. Early intervention and regular follow-up play a key role in improving long-term outcomes.
Most people with liver fibrosis do not need a liver transplant. However, if liver disease worsens to advanced liver failure despite treatment, specialized care may be needed. In some people with end-stage liver disease, liver transplant may be considered.
Self-care plays an important role in protecting liver health and slowing the worsening of liver fibrosis. Healthcare professionals may recommend specific self-care steps based on overall health and the cause of liver disease.
These steps may help support liver health:
If you have liver fibrosis, you may be referred to a doctor who specializes in the digestive system, called a gastroenterologist, or a doctor who is an expert in conditions of the liver, called a hepatologist.
Here's some information to help you get ready for your appointment and know what to expect.
Preparing a list of questions can help you make the most of your time. Basic questions may include:
Feel free to ask any additional questions during your appointment.
Be prepared to answer questions, such as:
Healthcare professionals often describe liver fibrosis in stages based on how much scar tissue is present in the liver. These stages help estimate how severe the scarring is and how likely the disease is to worsen over time.
Liver fibrosis is commonly described using stages from F0 to F4.
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use